fdareporter.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Sitemap: https://fdareporter.com/sitemaps/fdareporter/sitemap.xml.gz Sitemap: https://fdareporter.com/sitemaps/fdareporter/sitemap_news.xml.gz # Temporary throttles to decrease load during launch User-agent: Yandex Crawl-delay: 3 User-agent: Baiduspider Crawl-delay: 3 User-agent: bingbot Crawl-delay: 3 User-agent: Slurp Crawl-delay: 3 User-agent: * Disallow: /search Disallow: /*.json Disallow: /v.js Disallow: /ad.js User-agent: PetalBot Disallow: / User-agent: Barkrowler/0.9 Disallow: | ||
Meta Tags
| Title | FDA |
| Description | BAYER: U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint Data to NUBEQA® FDA Reporter is a trade journal for the U.S Food and Drug Administration's employees and contractors, covering personnel moves, budgets, acquisitions, contracting and hiring. This includes the Office of the Commissioner, Office of Operations, |
| Keywords | FDA Reporter |
Server Information
| WebSite | |
| Host IP | 54.152.78.38 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
fdareporter.com Valuation
|
US$578,342
Last updated: 2023-05-10 01:56:21
fdareporter.com has Semrush global rank of 18,301,130. fdareporter.com has an estimated worth of US$ 578,342, based on its estimated Ads revenue. fdareporter.com receives approximately 66,732 unique visitors each day. Its web server is located in United States, with IP address 54.152.78.38. According to SiteAdvisor, fdareporter.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$578,342 |
| Daily Ads Revenue | US$534 |
| Monthly Ads Revenue | US$16,016 |
| Yearly Ads Revenue | US$192,188 |
| Daily Unique Visitors | 4,449 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| fdareporter.com. | A | 3599 | IP: 54.152.78.38 |
| fdareporter.com. | NS | 86400 | NS Record: ns-1240.awsdns-27.org. |
| fdareporter.com. | NS | 86400 | NS Record: ns-149.awsdns-18.com. |
| fdareporter.com. | NS | 86400 | NS Record: ns-2033.awsdns-62.co.uk. |
| fdareporter.com. | NS | 86400 | NS Record: ns-689.awsdns-22.net. |
| fdareporter.com. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
| fdareporter.com. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
| fdareporter.com. | MX | 3600 | MX Record: 10 alt3.aspmx.l.google.com. |
| fdareporter.com. | MX | 3600 | MX Record: 10 alt4.aspmx.l.google.com. |
| fdareporter.com. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
| fdareporter.com. | TXT | 86400 | TXT Record: v=spf1 include:_spf.google.com ~all |
HtmlToTextCheckTime:2023-05-10 01:56:21
| FDA Reporter Tuesday, May 9, 2023 Tuesday, May 9, 2023 FDA Approval Regulation Reform Patients Drug Shortages Directory CLEAR Toggle navigation CLEAR FDA Approval Regulation Reform Patients Drug Shortages Directory Regulation Proposed FDA vaping regulations are ’extensive, outdated,’ AVA president says By Amanda Smith-Teutsch | Nov 6, 2019 Regulation FDA vaping regulations will hurt consumers, independents, CASAA says By Amanda Smith-Teutsch | Oct 31, 2019 Regulation FDA issued 13 warning letters in October By FDA Reporter Submission | Oct 30, 2019 Latest News BAYER: U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint Data to NUBEQA® (darolutamide) Prescribing Information FDA Approval By Press release submission | Jan 8, 2021 Phase III data showed treatment with NUBEQA resulted in a 31% reduction in risk of death, with a statistically significant improvement in overall survival (OS) compared to placebo (HR=0.69, 95% CI 0.53-0.88; p=0.003), giving men with |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: nginx/1.16.1 Date: Mon, 01 Nov 2021 22:56:16 GMT Content-Type: text/html Content-Length: 169 Connection: keep-alive Location: https://fdareporter.com/ Strict-Transport-Security: max-age=31536000; includeSubDomains HTTP/1.1 200 OK Server: nginx/1.16.1 Date: Mon, 01 Nov 2021 22:56:16 GMT Content-Type: text/html; charset=utf-8 Connection: keep-alive X-Frame-Options: SAMEORIGIN X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Last-Modified: Fri, 08 Jan 2021 18:45:00 GMT X-Runtime: 0.738011 Age: 5098130 Cache-Control: s-maxage=60,no-cache X-Cache: HIT X-Cache-Hits: 2603 ETag: W/"66cf31c8a2216279067401e79db1222e" Accept-Ranges: bytes Strict-Transport-Security: max-age=31536000; includeSubDomains |
fdareporter.com Whois Information
Domain Name: FDAREPORTER.COM Registry Domain ID: 2362387463_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-02-21T12:40:00Z Creation Date: 2019-02-20T15:42:25Z Registry Expiry Date: 2022-02-20T15:42:25Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1240.AWSDNS-27.ORG Name Server: NS-149.AWSDNS-18.COM Name Server: NS-2033.AWSDNS-62.CO.UK Name Server: NS-689.AWSDNS-22.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-20T07:20:41Z <<< |